Reuters logo
BRIEF-Protalix Biotherapeutics says presentation of clinical trial results for alidornase alfa
May 23, 2017 / 11:52 AM / 6 months ago

BRIEF-Protalix Biotherapeutics says presentation of clinical trial results for alidornase alfa

May 23 (Reuters) - Protalix Biotherapeutics Inc

* Protalix Biotherapeutics announces presentation of Phase II clinical trial results for Alidornase Alfa in cystic fibrosis at the 40th European cystic fibrosis society conference Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below